Interestingly, recent genome-wide studies have identified variants in a third adiponectin receptor, T-cadherin encoding CHD [13] that also affect circulating adiponectin levels, but unfortunately this information was not available in our study [28,30]. Here, ADIPOQ is linked to coronary artery disorder.